Morgan Lewis Global Public Company Academy

The Morgan Lewis Global Public Company Academy is a series of webinars designed to provide comprehensive advice and the latest regulatory and legal developments on matters relating to capital markets transactions, corporate governance, ESG issues, and executive compensation matters. The GPCA provides comprehensive training materials crafted for legal, accounting, human resources, and corporate governance and compliance professionals at public companies, as well as board members or others who are otherwise subject to or involved in reviewing public disclosure documents for these companies.

These webinars bring together Morgan Lewis’s securities, corporate governance, executive compensation, and litigation lawyers to cover updates on current developments impacting public companies. The program is set up so that each session is self-contained, and geared toward learning in an efficient and convenient format. Participants can pick topics of particular interest or relevance, or attend the entire series.

View the Global Public Company curriculum >>

For inquiries, please contact Kate Morgan.

Upcoming Webinars

05/14/2025 - Major Amendments to Delaware Corporate Law – Are You Ready?
In this session, our partners will break down the significant amendments to the Delaware General Corporation Law enacted on March 25, 2025—redefining rules around interested director and controlling stockholder transactions, stockholder information rights, and more.
05/21/2025 - Public Company SEC Enforcement Trends and Practical Considerations
Please join us for a webinar discussing key insights from a report prepared by members of our securities enforcement and corporate business transactions practices.
06/11/2025 - Ethics and Oversight: Corporate Governance Essentials for Public Companies
Join us for a review of the developing expectations for corporate compliance programs for public companies, with a special discussion of the role of a company’s code of ethics and how to avoid common disclosure footfalls when waivers from the code may be required.
07/09/2025 - 2025 Annual Meeting Postmortem: A Recap of Trends
Please join us for a recap discussion on corporate governance trends in 2025.
07/23/2025 - Back to Basics: Equity Awards
Join us for a refresher on common issues raised with respect to equity awards.

Past Webinars

03/19/2025 - Recent Developments in Debt & Equity Offerings
This installment of the GPCA will focus on the need for liquidity and recent trends in equity and debt markets.
01/29/2025 - Preparing for the 2025 Proxy Season: A Recap of 2024 Proxies and Trends to Watch
Join us as we delve into the issues that you will be grappling with in this upcoming proxy season and share best practices.
01/22/2025 - Navigating ESG & DEI Disclosure Issues for Public Companies: What’s New for 2025
As we begin 2025, with the transition to a new presidential administration, US public companies are considering how to address corporate social responsibility (CSR); sustainability; environmental, social, and governance (ESG); and diversity, equity, and inclusion (DEI) issues. This includes how to craft public disclosures and engage with stakeholders. Our panelists will discuss the latest trends in disclosure considerations applicable to US public companies, including multinationals, against the backdrop of a continually shifting regulatory and litigation landscape.
12/11/2024 - ESG Regulatory Regimes: Navigating Competing Jurisdictions
Join us as we explore ESG legislation across multiple jurisdictions and the challenges of navigating conflicting regulatory requirements. We will discuss the anticipated actions of the new Trump-Vance administration as well as the implementation of regulations including California’s new climate disclosure laws and EU ESG directives. The session will also cover the potential use of antitrust laws to address alleged collusion in ESG/diversity, equity, and inclusion (DEI) activities.
10/30/2024 - Disclosure Issues in the Life Sciences Industry
Join us in discussing disclosure considerations for public companies in the life sciences sector. Our speakers will delve into the industry’s intricacies and challenges, with a particular emphasis on the nuances relevant to biotech companies.
09/25/2024 - Securities Litigation Update
This session will review headline-making cases and trends shaping our capital and financial markets. The panel will cover recent trends, cases in securities class actions, and recent decisions from Delaware’s Supreme Court and the Court of Chancery.
07/17/2024 - 2024 Annual Meeting Postmortem: A Recap of Trends
Please join us for a recap discussion on corporate governance trends in 2024.
05/29/2024 - Key insights on Navigating Compliance with the Corporate Sustainability Reporting Directive (CSRD)
Join Morgan Lewis and KPMG for a conversation that will focus on the complexities of corporate sustainability reporting obligations in the EU, with a particular emphasis on the Corporate Sustainability Reporting Directive (CSRD) and European Sustainability Reporting Standards (ESRS).
05/22/2024 - Public Company SEC Enforcement Trends and Practical Considerations
The US Securities and Exchange Commission (SEC) continued its heightened focus on public companies in 2023 through its enforcement and rulemaking programs, a trend that will likely continue throughout 2024. Recent enforcement activity points to several areas of interest for the SEC, including whistleblowers, ESG, cybersecurity, insider trading, and executive perks, among many others, as laid out in more detail in our report.
05/13/2024 - Key Insights on Navigating the EU Corporate Sustainability Due Diligence Directive (CS3D)
Join us as we unravel the complexities of the Corporate Sustainability Due Diligence Directive (CS3D) and offer practical guidance and knowledgeable perspectives on navigating the evolving EU regulatory landscape.